Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 67 | 335,961,131 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | EQUITIES | 251 | $486,091 | 561,955 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
| Aligos Therapeutics Inc | EQUITIES | 252 | $443,892 | 668,512 | 0.00 | 0.00 | 36,625 | 5.80 | 12-31-2023 |
| Relmada Therapeutics Inc | EQUITIES | 253 | $414,000 | 100,000 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
| Eliem Therapeutics Inc | EQUITIES | Liquidated | $0 | 0 | 0.00 | 0.00 | -372,979 | -75.49 | 12-31-2023 |
